A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

Timo Vesikari; Martine Baudin; Nicholas Brodszki; Pierre van Damme; Javier Diez-Domingo; Giancarlo Icardi; Lone Kjeld Petersen; Clément Tran; Stéphane Thomas; Luxembourg Alain

doi:10.1097/INF.0000000000000773

A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

Timo Vesikari, Martine Baudin, Nicholas Brodszki, Pierre van Damme, Javier Diez-Domingo, Giancarlo Icardi, Lone Kjeld Petersen, Clément Tran, Stéphane Thomas, Luxembourg Alain

Research output: Contribution to journal › Article › Scientific › peer-review

106 Citations (Scopus)

Original language	English
Pages (from-to)	992-998
Journal	Pediatric Infectious Disease Journal
Volume	34
Issue number	9
DOIs	https://doi.org/10.1097/INF.0000000000000773
Publication status	Published - 2015
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/INF.0000000000000773

Cite this

Vesikari, T., Baudin, M., Brodszki, N., van Damme, P., Diez-Domingo, J., Icardi, G., Petersen, L. K., Tran, C., Thomas, S., & Alain, L. (2015). A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls. Pediatric Infectious Disease Journal, 34(9), 992-998. https://doi.org/10.1097/INF.0000000000000773

@article{5cf416de6e164f9185b8f0e79898a015,

title = "A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil{\textregistered} in 9-15-Year-Old Girls",

author = "Timo Vesikari and Martine Baudin and Nicholas Brodszki and {van Damme}, Pierre and Javier Diez-Domingo and Giancarlo Icardi and Petersen, {Lone Kjeld} and Cl{\'e}ment Tran and St{\'e}phane Thomas and Luxembourg Alain",

year = "2015",

doi = "10.1097/INF.0000000000000773",

language = "English",

volume = "34",

pages = "992--998",

journal = "Pediatric Infectious Disease Journal",

issn = "0891-3668",

publisher = "Lippincott, Williams & Wilkins",

number = "9",

}

Vesikari, T, Baudin, M, Brodszki, N, van Damme, P, Diez-Domingo, J, Icardi, G, Petersen, LK, Tran, C, Thomas, S & Alain, L 2015, 'A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls', Pediatric Infectious Disease Journal, vol. 34, no. 9, pp. 992-998. https://doi.org/10.1097/INF.0000000000000773

A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls. / Vesikari, Timo; Baudin, Martine; Brodszki, Nicholas et al.
In: Pediatric Infectious Disease Journal, Vol. 34, No. 9, 2015, p. 992-998.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

AU - Vesikari, Timo

AU - Baudin, Martine

AU - Brodszki, Nicholas

AU - van Damme, Pierre

AU - Diez-Domingo, Javier

AU - Icardi, Giancarlo

AU - Petersen, Lone Kjeld

AU - Tran, Clément

AU - Thomas, Stéphane

AU - Alain, Luxembourg

PY - 2015

Y1 - 2015

U2 - 10.1097/INF.0000000000000773

DO - 10.1097/INF.0000000000000773

M3 - Article

SN - 0891-3668

VL - 34

SP - 992

EP - 998

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

IS - 9

ER -